Cart
sales@molnova.com
Gingerglycolipid A
CAS No. 145937-22-0
Gingerglycolipid A( —— )
Catalog No. M32256 CAS No. 145937-22-0
Gingerglycolipid A is a monoacyldigalactosyl glycerol.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameGingerglycolipid A
-
NoteResearch use only, not for human use.
-
Brief DescriptionGingerglycolipid A is a monoacyldigalactosyl glycerol.
-
DescriptionGingerglycolipid A is a monoacyldigalactosyl glycerol.
-
In VitroGingerglycolipid A seems to be differentially accumulated depending on the ripening stage and the treatment with NO.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number145937-22-0
-
Formula Weight676.79
-
Molecular FormulaC33H56O14
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
6-Hydroxykaempferol ...
6-Hydroxykaempferol 3,6-di-O-glucoside and 6-hydroxykaempferol 3,6,7-tri-O-glucoside can inhibit platelet aggregation induced by collagen, they also show weak inhibitory effects on the adenosine 5'-diphosphate (ADP)- induced platelet aggregation.
-
Isoviolanthin
Isoviolanthin reduces the migratory and invasive capacities of TGF-β1-treated HCC cells but exhibits no cytotoxic effects on normal live cells, and has potential as a therapeutic agent for the treatment of advanced-stage metastatic HCC.
-
2614W94
2614W94 is a selective, competitive, and reversible inhibitor of monoamine oxidase-A with IC50 of 5 nM and Ki of 1.6 nM with serotonin as a substrate.
